Schedule of Investor Meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has disclosed the schedule for upcoming meetings with analysts and institutional investors from May 21-29, 2026. Three meetings are planned: a one-on-one with Carnelian Asset Management on May 21, participation in 360 ONE Capital's investor conference on May 27 involving both one-on-one and group meetings, and a one-on-one with Ashmore Investment Management on May 29. The company has noted that schedules may change due to exigencies. This filing complies with SEBI's Regulation 30 for continuous disclosure obligations.
This is a routine regulatory disclosure indicating active investor relations engagement. No direct impact on stock price expected, though regular meetings with institutional investors can support shareholder confidence and potentially attract new institutional interest in the stock.